华夏上证科创板生物医药ETF发起式联接C(027143) - 基金对比
最后更新于：2026-05-08
非全收益率指数点位的计算不包含分红再投入，所以理论上指数基金的分红再投入收益率高于其对应的指数点位涨幅。
加载中......
| 日期 | 华夏上证科创板生物医药ETF发起式联接C - 相对起始点分红再投入收益率 | 科创生物 - 相对起始点收益率 |
|---|---|---|
| 2026-05-08 | -3.38% | 9.94% |
| 2026-05-07 | -2.52% | 10.99% |
| 2026-05-06 | -3.50% | 9.78% |
| 2026-04-30 | -4.24% | 8.84% |
| 2026-04-29 | -4.57% | 8.43% |
| 2026-04-28 | -4.46% | 8.57% |
| 2026-04-27 | -3.54% | 9.70% |
| 2026-04-24 | -4.05% | 9.08% |
| 2026-04-23 | -3.05% | 10.30% |
| 2026-04-22 | -1.51% | 12.18% |
| 2026-04-21 | -2.54% | 10.94% |
| 2026-04-20 | -1.52% | 12.17% |
| 2026-04-17 | -1.11% | 12.66% |
| 2026-04-16 | 0% | 14.57% |